binx health Adds Industry Leaders, Elizabeth Mora and Naomi Kelman to Board of Directors
binx health, a healthcare technology and diagnostics company that brings convenient care to the locations where people live, work, study and shop, today announced the appointments of Elizabeth Mora and Naomi Kelman to its Board of Directors. Ms. Mora has also been appointed Chair of the company’s Audit Committee.
“As accomplished, visionary leaders, with a unique passion for healthcare innovation and care access, we are thrilled to welcome Beth and Naomi to our Board of Directors,” Jeff Luber, Chief Executive Officer of binx health. “As the ‘front door’ of healthcare rapidly moves to decentralized locations and into the home, Beth’s and Naomi’s diverse backgrounds and wealth of expertise at the nexus of technology, healthcare, laboratory services, and consumer health, are ideally suited to advance our ‘everywhere care’ mission.”
“binx’s ‘everywhere care’ approach to test access is an exciting development in the field of healthcare diagnostics. I am pleased to be joining Jeff and the team as we chart a course to better care,” said Ms. Mora.
“Having helped build some of the nation’s most well-known consumer health brands, I’m excited to lend my voice to binx health’s ‘everywhere care’ mission,” said Ms. Kelman.
About Elizabeth Mora
Ms. Mora brings over 30 years of financial and operational experience to binx health. Most recently, Ms. Mora was Chief Administrative Officer and Chief Financial Officer of Draper Laboratory, where she managed operations related to finance, information technology, human resources, facilities and security. Previously, she served as Chief Financial Officer of Harvard University, and Senior Manager at PriceWaterhouseCoopers LLP where she oversaw audits, prepared financial statements and managed additional accounting projects. She currently serves as Board director and audit committee chair of MKS Instruments and Board director and audit committee member of INOGEN, Inc. Ms. Mora holds an M.B.A. from Simmons College Graduate School of Management, and a B.A. in Political Science from the University of California, Berkeley. She is a certified public accountant in The Commonwealth of Massachusetts.
About Naomi Kelman
Ms. Kelman joins binx health with over two decades of experience in the Life Sciences industry. Most recently, she served as President and Chief Executive Officer of Willow Innovations Inc. Earlier in her career, Ms. Kelman was Global Division Head of Novartis OTC at Novartis AG, and held various executive leadership roles at Johnson & Johnson, including President of Vistakon (Acuvue contact lenses) and President of LifeScan (OneTouch diabetes monitor). Before joining Johnson & Johnson, she worked at Clairol (formerly Bristol-Myers Squibb) and American Express Company. She currently serves on the Board of Directors of National Vision Holdings, Kids Care Dental & Orthodontics, Mirvie, Inc and Brilliant Home Technology Inc. Ms. Kelman holds an M.B.A. and a B.A. in Economics from Cornell University.
Companies In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more